HitGen LTD:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:HitGen LTD - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11216
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
HitGen LTD (HitGen) is a drug company that concentrates on hit identification and lead generation in the early phases of drug discoveries and development. The company provides OpenDEL, a collection of DNA encoded library compounds based on distinct, diverse and drug structures. It offers biological reagents, edge technology and services for progression of projects and services. HitGen provides services such as lead generation by DNA encoded chemical libraries; hit to lead expansion and lead optimization; custom compound and compound library synthesis and others. The company’s research support capabilities comprise protein expression and purification, chemical library design and synthesis, in-vitro screening and affinity selection, among others. It caters contract research organizations and pharmaceutical industries. HitGen is headquartered in Chengdu, China.

HitGen LTD – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
HitGen LTD, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
HitGen LTD, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
HitGen LTD, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
HitGen LTD, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
HitGen LTD, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
HitGen LTD, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
HitGen Raises USD39.1 Million in Series B Venture Financing 11
Partnerships 12
HitGen Enters into Research Agreement with LG Chem Life Sciences 12
HitGen Enters into Research Collaboration Agreement with Sanofi 13
HitGen Enters into Research Agreement with Boehringer Ingelheim 14
HitGen Enters into Agreement with Takeda Pharma 15
Cocrystal Pharma Enters into Research Agreement with HitGen and InterX 16
HitGen Enters into Agreement with Aduro Biotech 17
HitGen Enters into Research Agreement with LEO Pharma 18
HitGen Enters into Partnership with Scripps Research Institute and California Institute for Biomedical Research 19
HitGen Expands Agreement with Merck 20
HitGen Enters into Agreement with Janssen Biotech 21
HitGen Enters into Research Agreement with Global Blood Therapeutics 22
HitGen Enters into Drug Discovery Agreement with Cancer Research UK and Cancer Research Technology 23
HitGen Enters Into Distribution Agreement With Tecrea For HappyFect And NanoCargo 24
Licensing Agreements 25
Forma Therapeutics and HitGen Enter into Licensing Agreement 25
HitGen Enters into Licensing Agreement with Simcere Pharma 26
Pfizer Enters into Licensing Agreement with HitGen 27
Cancer Research UK and Cancer Research Technology Enter into Licensing Agreement with HitGen 28
HitGen LTD – Key Competitors 29
HitGen LTD – Key Employees 30
HitGen LTD – Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31
Recent Developments 32
Government and Public Interest 32
Aug 03, 2018: HitGen launching initiative to discover new medicines to combat tuberculosis and malaria 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
HitGen LTD, Pharmaceuticals & Healthcare, Key Facts 2
HitGen LTD, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
HitGen LTD, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
HitGen LTD, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
HitGen LTD, Deals By Therapy Area, 2012 to YTD 2018 8
HitGen LTD, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
HitGen Raises USD39.1 Million in Series B Venture Financing 11
HitGen Enters into Research Agreement with LG Chem Life Sciences 12
HitGen Enters into Research Collaboration Agreement with Sanofi 13
HitGen Enters into Research Agreement with Boehringer Ingelheim 14
HitGen Enters into Agreement with Takeda Pharma 15
Cocrystal Pharma Enters into Research Agreement with HitGen and InterX 16
HitGen Enters into Agreement with Aduro Biotech 17
HitGen Enters into Research Agreement with LEO Pharma 18
HitGen Enters into Partnership with Scripps Research Institute and California Institute for Biomedical Research 19
HitGen Expands Agreement with Merck 20
HitGen Enters into Agreement with Janssen Biotech 21
HitGen Enters into Research Agreement with Global Blood Therapeutics 22
HitGen Enters into Drug Discovery Agreement with Cancer Research UK and Cancer Research Technology 23
HitGen Enters Into Distribution Agreement With Tecrea For HappyFect And NanoCargo 24
Forma Therapeutics and HitGen Enter into Licensing Agreement 25
HitGen Enters into Licensing Agreement with Simcere Pharma 26
Pfizer Enters into Licensing Agreement with HitGen 27
Cancer Research UK and Cancer Research Technology Enter into Licensing Agreement with HitGen 28
HitGen LTD, Key Competitors 29
HitGen LTD, Key Employees 30
HitGen LTD, Subsidiaries 31

List of Figures
HitGen LTD, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
HitGen LTD, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
HitGen LTD, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
HitGen LTD, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
HitGen LTD, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
HitGen LTD, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
HitGen LTD, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
HitGen LTD, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[HitGen LTD:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • 01 Communique (ONE):企業の財務・戦略的SWOT分析
    Summary 01 Communique (Communique) is a technology company that develops and delivers integrated communication software and services. The company's products include I'm InTouch meeting, I'm InTouch, I'm OnCall and Communicate!. Communique I'm InTouch provides a secure and easy to use PC remote acces …
  • Lipocine Inc (LPCN):企業の財務・戦略的SWOT分析
    Summary Lipocine Inc (Lipocine) operates as a pharmaceutical company that develops and commercializes treatment for men's and women's health. The company’s pipeline products for men’s health include LPCN 1111 and LPCN 1021; and for women’s health include LPCN 1107. Its LPCN 1111 is an oral testoster …
  • Krispy Kreme Doughnuts, Inc.:企業の戦略的SWOT分析
    Krispy Kreme Doughnuts, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Sinohydro Corporation Co Ltd-エネルギー分野:企業M&A・提携分析
    Summary Sinohydro Corporation Co., Ltd (Sinohydro) a subsidiary ofPower Construction Corporation of Chinais a global engineering and construction company. It is a state-owned hydropower project contractor with focus on the development of residential, commercial, and industrial properties across the …
  • IBEX Technologies Inc (IBT):企業の財務・戦略的SWOT分析
    Summary IBEX Technologies Inc (IBEX) is a manufacturer and marketer of high-purity proprietary enzymes and recombinant from flavobacterium heparinum. The company provides enzymes such as heparinase I, heparinase II, heparinase III, chondroitinase AC and chondroitinase B. Its assays allow for the stu …
  • Haier Group:企業の戦略・SWOT・財務情報
    Haier Group - Strategy, SWOT and Corporate Finance Report Summary Haier Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Ergon, Inc.:石油・ガス:M&Aディール及び事業提携情報
    Summary Ergon Inc (Ergon) is an integrated energy company that carries out the exploration and production of crude oil and natural gas, processing, transportation and terminaling of crude oil, storage, marketing and distribution of specialty petroleum products. The company also manufactures and mark …
  • Amryt Pharma plc (AMYT):製薬・医療:M&Aディール及び事業提携情報
    Summary Amryt Pharma plc (Amryt) is a specialty pharmaceutical company that develops, manufactures and commercializes novel treatments for patients with rare and orphan diseases. It has two marketed products include Lojuxta for the treatment of adult HoFH and Episalvan for the treatment of PTW. The …
  • Ashapura Minechem Ltd.:企業の戦略・SWOT・財務分析
    Ashapura Minechem Ltd. - Strategy, SWOT and Corporate Finance Report Summary Ashapura Minechem Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Energy Recovery Inc (ERII):企業の財務・戦略的SWOT分析
    Energy Recovery Inc (ERII) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Goa Shipyard Ltd:企業の戦略・SWOT・財務情報
    Goa Shipyard Ltd - Strategy, SWOT and Corporate Finance Report Summary Goa Shipyard Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Bandwidth Inc (BAND):企業の財務・戦略的SWOT分析
    Bandwidth Inc (BAND) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Mitsui O.S.K. Lines, Ltd.:企業の戦略・SWOT・財務情報
    Mitsui O.S.K. Lines, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mitsui O.S.K. Lines, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • IndusInd Bank Ltd:戦略・SWOT・企業財務分析
    IndusInd Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary IndusInd Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Wolverine Power Supply Cooperative Inc:企業の戦略的SWOT分析
    Wolverine Power Supply Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Walchandnagar Industries Ltd:企業の戦略・SWOT・財務分析
    Walchandnagar Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Walchandnagar Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Dundee Corporation:企業のM&A・事業提携・投資動向
    Dundee Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Dundee Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Reyes Holdings, L.L.C.:企業の戦略・SWOT・財務分析
    Reyes Holdings, L.L.C. - Strategy, SWOT and Corporate Finance Report Summary Reyes Holdings, L.L.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Electricidade de Mocambique EP:企業の戦略的SWOT分析
    Electricidade de Mocambique EP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Rohto Pharmaceutical Co Ltd (4527):企業の財務・戦略的SWOT分析
    Rohto Pharmaceutical Co Ltd (4527) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆